Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$26.85 USD
-0.48 (-1.76%)
Updated May 23, 2024 04:00 PM ET
After-Market: $26.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.93 | 0.00% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This reflects a positive earnings surprise of 2.08%. Look out for RPRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.93 per share, reflecting a year-over-year increase of 9.41%.
Earnings History
Price & Consensus
Zacks News for RPRX
Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services